Darin Lippoldt, Chief Legal Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 2,500 shares at $152.91 ($382K) on 2025-01-31, disclosed to the SEC on 2025-02-04.
Scheduled sale ($382k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $152.91 | 1,250 | $191K | 50.0% |
| 2 | $152.91 | 1,250 | $191K | 50.0% |
| Total | $152.91 avg | 2,500 | $382K | 100% |
| Filing → |
| NBIX | SELL | 2025-12-10 | $1.4M | — | Filing → |
| NBIX | SELL | 2025-02-14 | $510K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $215K | — | Filing → |